USD 0.51
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -15.31 Million USD | -17.52% |
2022 | -13.03 Million USD | -470.28% |
2021 | -2.28 Million USD | -189.97% |
2020 | -788 Thousand USD | -168.03% |
2019 | -294 Thousand USD | -100.35% |
2018 | 84 Million USD | 124.91% |
2017 | 37.35 Million USD | 4.15% |
2016 | 35.86 Million USD | 52.1% |
2015 | 23.57 Million USD | 105.69% |
2014 | 11.46 Million USD | 36.53% |
2013 | 8.39 Million USD | 279.74% |
2012 | 2.21 Million USD | 120.73% |
2011 | -10.66 Million USD | 29.09% |
2010 | -15.03 Million USD | -96.11% |
2009 | -7.66 Million USD | -152.63% |
2008 | 14.57 Million USD | 5930.77% |
2007 | 241.61 Thousand USD | 105.38% |
2006 | -4.48 Million USD | -114.51% |
2005 | 30.93 Million USD | 253.93% |
2004 | -20.09 Million USD | -57.94% |
2003 | -12.72 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -4.78 Million USD | -16.43% |
2024 Q2 | -5.09 Million USD | -6.4% |
2023 Q3 | -3.73 Million USD | -12.83% |
2023 Q2 | -3.31 Million USD | 20.31% |
2023 Q4 | -4.1 Million USD | -9.95% |
2023 FY | -15.31 Million USD | -17.52% |
2023 Q1 | -4.15 Million USD | -11.15% |
2022 Q3 | -3.61 Million USD | -2.12% |
2022 Q2 | -3.53 Million USD | -64.88% |
2022 Q1 | -2.14 Million USD | -59.88% |
2022 FY | -13.03 Million USD | -470.28% |
2022 Q4 | -3.73 Million USD | -3.57% |
2021 Q2 | -337 Thousand USD | -106.75% |
2021 Q4 | -1.34 Million USD | -200.67% |
2021 Q1 | -163 Thousand USD | 37.55% |
2021 Q3 | -446 Thousand USD | -32.34% |
2021 FY | -2.28 Million USD | -189.97% |
2020 Q1 | -100 Thousand USD | -100.47% |
2020 Q2 | -154 Thousand USD | -54.0% |
2020 Q3 | -272 Thousand USD | -76.62% |
2020 Q4 | -261 Thousand USD | 4.04% |
2020 FY | -788 Thousand USD | -168.03% |
2019 Q4 | 21.34 Million USD | -9.0% |
2019 FY | -294 Thousand USD | -100.35% |
2019 Q2 | 23.32 Million USD | 14.2% |
2019 Q1 | 20.42 Million USD | -15.58% |
2019 Q3 | 23.45 Million USD | 0.55% |
2018 Q1 | 15.47 Million USD | -3.76% |
2018 FY | 84 Million USD | 124.91% |
2018 Q2 | 20.88 Million USD | 35.0% |
2018 Q3 | 23.44 Million USD | 12.26% |
2018 Q4 | 24.19 Million USD | 3.19% |
2017 Q4 | 16.07 Million USD | 155.57% |
2017 Q1 | 5.69 Million USD | -30.44% |
2017 FY | 37.35 Million USD | 4.15% |
2017 Q2 | 9.28 Million USD | 62.92% |
2017 Q3 | 6.29 Million USD | -32.23% |
2016 Q4 | 8.19 Million USD | -15.68% |
2016 Q2 | 9.16 Million USD | 4.25% |
2016 Q1 | 8.79 Million USD | 39.03% |
2016 FY | 35.86 Million USD | 52.1% |
2016 Q3 | 9.71 Million USD | 5.98% |
2015 Q1 | 4.66 Million USD | 29.07% |
2015 FY | 23.57 Million USD | 105.69% |
2015 Q4 | 6.32 Million USD | -4.62% |
2015 Q3 | 6.63 Million USD | 11.28% |
2015 Q2 | 5.95 Million USD | 27.69% |
2014 Q2 | 3.22 Million USD | 117.56% |
2014 Q3 | 3.35 Million USD | 4.03% |
2014 Q4 | 3.61 Million USD | 7.85% |
2014 FY | 11.46 Million USD | 36.53% |
2014 Q1 | 1.48 Million USD | -47.52% |
2013 FY | 8.39 Million USD | 279.74% |
2013 Q3 | 1.66 Million USD | -26.48% |
2013 Q1 | 1.63 Million USD | -81.51% |
2013 Q4 | 2.82 Million USD | 69.08% |
2013 Q2 | 2.27 Million USD | 38.84% |
2012 Q2 | -935 Thousand USD | 71.76% |
2012 Q4 | 8.84 Million USD | 470.73% |
2012 FY | 2.21 Million USD | 120.73% |
2012 Q1 | -3.31 Million USD | -99.82% |
2012 Q3 | -2.38 Million USD | -155.08% |
2011 FY | -10.66 Million USD | 29.09% |
2011 Q1 | -1.46 Million USD | 62.13% |
2011 Q2 | -2.02 Million USD | -38.16% |
2011 Q3 | -5.51 Million USD | -172.63% |
2011 Q4 | -1.65 Million USD | 69.97% |
2010 FY | -15.03 Million USD | -96.11% |
2010 Q4 | -3.86 Million USD | 41.78% |
2010 Q3 | -6.64 Million USD | -542.65% |
2010 Q1 | 1.15 Million USD | 120.42% |
2010 Q2 | -1.03 Million USD | -189.91% |
2009 FY | -7.66 Million USD | -152.63% |
2009 Q4 | -5.63 Million USD | -18.44% |
2009 Q1 | 794 Thousand USD | -87.8% |
2009 Q2 | 1.92 Million USD | 142.95% |
2009 Q3 | -4.75 Million USD | -346.55% |
2008 Q2 | 3.14 Million USD | 406.25% |
2008 Q4 | 6.5 Million USD | 51.62% |
2008 FY | 14.57 Million USD | 5930.77% |
2008 Q1 | 621.62 Thousand USD | 100.94% |
2008 Q3 | 4.29 Million USD | 36.42% |
2007 Q1 | 14.11 Million USD | 145.3% |
2007 Q3 | 22.23 Million USD | 1485.08% |
2007 Q4 | -66.46 Million USD | -398.91% |
2007 Q2 | -1.6 Million USD | -111.38% |
2007 FY | 241.61 Thousand USD | 105.38% |
2006 Q3 | 8.88 Million USD | 10.07% |
2006 FY | -4.48 Million USD | -114.51% |
2006 Q4 | -31.14 Million USD | -450.5% |
2006 Q2 | 8.07 Million USD | 0.0% |
2006 Q1 | 8.07 Million USD | 0.0% |
2005 FY | 30.93 Million USD | 253.93% |
2004 FY | -20.09 Million USD | -57.94% |
2003 FY | -12.72 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
CareCloud, Inc. | -47.11 Million USD | 67.497% |
Augmedix, Inc. | -18.77 Million USD | 18.451% |
BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | 110.405% |
CareCloud, Inc. | -47.11 Million USD | 67.497% |
HealthEquity, Inc. | 128.13 Million USD | 111.952% |
iCoreConnect Inc. | -10.27 Million USD | -49.018% |
Inovalon Holdings, Inc. | 71.71 Million USD | 121.355% |
Nutex Health, Inc. | -31.77 Million USD | 51.803% |
Omnicell, Inc. | -34.86 Million USD | 56.08% |
OneMedNet Corporation | -8.37 Million USD | -82.87% |
Progyny, Inc. | 62.18 Million USD | 124.627% |
Renalytix Plc | -29.6 Million USD | 48.277% |
Schrödinger, Inc. | -177.44 Million USD | 91.37% |
Simulations Plus, Inc. | 6.13 Million USD | 349.78% |
SOPHiA GENETICS SA | -74.82 Million USD | 79.534% |
Streamline Health Solutions, Inc. | -19.64 Million USD | 22.054% |
Ontrak, Inc. | -20.67 Million USD | 25.93% |
GE HealthCare Technologies Inc. | 2.43 Billion USD | 100.629% |
Sharecare, Inc. | -96.47 Million USD | 84.126% |
Aclarion, Inc. | -4.87 Million USD | -214.07% |
CareMax, Inc. | -656.15 Million USD | 97.666% |
Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | -185.308% |
Forian Inc. | -5.59 Million USD | -173.708% |
Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | -185.308% |
GeneDx Holdings Corp. | -163.66 Million USD | 90.643% |
SCWorx Corp. | -1.45 Million USD | -955.656% |
Minerva Surgical, Inc. | -30.89 Million USD | 50.439% |
Definitive Healthcare Corp. | -329.8 Million USD | 95.357% |
10x Genomics, Inc. | -265.32 Million USD | 94.228% |
Zhongchao Inc. | -13.28 Million USD | -15.283% |
Accolade, Inc. | -114.45 Million USD | 86.62% |
MSP Recovery, Inc. | -559.87 Million USD | 97.265% |
R1 RCM Inc. | 147.9 Million USD | 110.354% |
Spok Holdings, Inc. | 21.22 Million USD | 172.141% |
Privia Health Group, Inc. | 20.64 Million USD | 174.163% |
EUDA Health Holdings Limited | -3.96 Million USD | -286.614% |
TruBridge, Inc. | -42.6 Million USD | 64.055% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | 110.405% |
Sharecare, Inc. | -96.47 Million USD | 84.126% |
Health Catalyst, Inc. | -126.89 Million USD | 87.932% |
GoodRx Holdings, Inc. | -27 Million USD | 43.296% |
Premier, Inc. | 157.08 Million USD | 109.749% |
HealthStream, Inc. | 16.01 Million USD | 195.599% |
Certara, Inc. | -40.77 Million USD | 62.442% |
GeneDx Holdings Corp. | -163.66 Million USD | 90.643% |
Ontrak, Inc. | -20.67 Million USD | 25.93% |
SHL Telemedicine Ltd. | -9 Million USD | -70.042% |
CareCloud, Inc. | -47.11 Million USD | 67.497% |
EUDA Health Holdings Limited | -3.96 Million USD | -286.614% |
HeartBeam, Inc. | -15.31 Million USD | -0.0% |
Mangoceuticals, Inc. | -9.21 Million USD | -66.115% |
CareMax, Inc. | -656.15 Million USD | 97.666% |
Healthcare Triangle, Inc. | -11.34 Million USD | -34.949% |
National Research Corporation | 40.04 Million USD | 138.242% |
Aclarion, Inc. | -4.87 Million USD | -214.07% |
OptimizeRx Corporation | -26.4 Million USD | 41.996% |